266 related articles for article (PubMed ID: 17042149)
1. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data.
Stern L; Berman J; Lumry W; Katz L; Wang L; Rosenblatt L; Doyle JJ
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):402-8. PubMed ID: 17042149
[TBL] [Abstract][Full Text] [Related]
2. Ratio of controller to total asthma medications: determinants of the measure.
Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
[TBL] [Abstract][Full Text] [Related]
3. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database.
Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford WW; Sajjan SG; Allen-Ramey F
Am J Manag Care; 2010 May; 16(5):327-33. PubMed ID: 20469953
[TBL] [Abstract][Full Text] [Related]
4. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
5. The relationship of sex to asthma prevalence, health care utilization, and medications in a large managed care organization.
Schatz M; Camargo CA
Ann Allergy Asthma Immunol; 2003 Dec; 91(6):553-8. PubMed ID: 14700439
[TBL] [Abstract][Full Text] [Related]
6. Process quality measures and asthma exacerbations in the medicaid population.
Yong PL; Werner RM
J Allergy Clin Immunol; 2009 Nov; 124(5):961-6. PubMed ID: 19748660
[TBL] [Abstract][Full Text] [Related]
7. [Predictive factors associated with severity of asthma exacerbations].
Atiş S; Kaplan ES; Ozge C; Bayindir S
Tuberk Toraks; 2008; 56(2):187-96. PubMed ID: 18701979
[TBL] [Abstract][Full Text] [Related]
8. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of risk factors and health outcomes among persons with asthma.
Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
Lage MJ; Gross GN; Brewster C; Spalitto A
Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
[TBL] [Abstract][Full Text] [Related]
11. Physician adherence to the national asthma prescribing guidelines: evidence from national outpatient survey data in the United States.
Navaratnam P; Jayawant SS; Pedersen CA; Balkrishnan R
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):216-21. PubMed ID: 18426140
[TBL] [Abstract][Full Text] [Related]
12. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
[TBL] [Abstract][Full Text] [Related]
13. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
Luskin A; Bukstein D; Kocevar VS; Yin DD
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
[TBL] [Abstract][Full Text] [Related]
14. Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data.
O'Connor RD; Bleecker ER; Long A; Tashkin D; Peters S; Klingman D; Gutierrez B
J Asthma; 2010 May; 47(4):422-8. PubMed ID: 20528597
[TBL] [Abstract][Full Text] [Related]
15. Urban minority children with asthma: substantial morbidity, compromised quality and access to specialists, and the importance of poverty and specialty care.
Flores G; Snowden-Bridon C; Torres S; Perez R; Walter T; Brotanek J; Lin H; Tomany-Korman S
J Asthma; 2009 May; 46(4):392-8. PubMed ID: 19484676
[TBL] [Abstract][Full Text] [Related]
16. Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone.
Allen-Ramey FC; Markson LE; Riedel AA; Sajjan S; Weiss KB
Curr Med Res Opin; 2006 Aug; 22(8):1453-61. PubMed ID: 16870071
[TBL] [Abstract][Full Text] [Related]
17. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes.
Berger WE; Legorreta AP; Blaiss MS; Schneider EC; Luskin AT; Stempel DA; Suissa S; Goodman DC; Stoloff SW; Chapman JA; Sullivan SD; Vollmer B; Weiss KB
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):538-45. PubMed ID: 15609762
[TBL] [Abstract][Full Text] [Related]
18. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
19. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
[TBL] [Abstract][Full Text] [Related]
20. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care.
Taira DA; Wong KS; Frech-Tamas F; Chung RS
Am J Manag Care; 2006 Nov; 12(11):678-83. PubMed ID: 17090224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]